One hypothesis that arises in light of these results is that, in cervical cancer, there may be a positive feedback loop, in which EGFR positively regulates uPA expression, and that its receptor, uPAR, may favor EGFR transactivation, as has been shown in glioblastoma (19). The gene discussed is PLAU; the disease is glioblastoma.